Home  Feedback  Career  Sitemap  Contact Us
 
Market Buzz
Corporate Info
Market Analysis
Movers
Corporate Action
Other Markets
IPO
 
Bombay Burmah ( 23-May-17 )
Bombay Burmah Trading Corporation has allotted 1500 secured, redeemable, Non Convertible Debentures of face value of Rs 10 lakh each aggregating Rs 150 crore on private placement basis on 23 May 2017.
Citurgia Biochem ( 23-May-17 )
Citurgia Biochemicals will hold a meeting of the Board of Directors of the Company on 29 May 2017, to consider and approve the Audited Financial Results of the Company for the quarter and year ended on 31st March, 2017.
DCM ( 23-May-17 )
DCM will hold a meeting of the Board of Directors of the Company on 30 May 2017.
Gajra Bevel ( 23-May-17 )
Gajra Bevel Gears will hold a meeting of the Board of Directors of the Company on 30 May 2017.
Grindwell Norton ( 23-May-17 )
Grindwell Norton announced that the Board of Directors of the Company at its meeting held on 23 May 2017 has appointed Krishna Kumar Prasad as an Alternate Director to Marie-Armelle Chupin, Non-Executive Director. Krishna Kumar Prasad is designated as Executive Director of the Company for a period of five (5) years with effect from 23 May 2017.
Akzo Nobel ( 23-May-17 )
Akzo Nobel India announced that the Board of Directors of the Company at its meeting held on 18 May 2017, inter alia, have recommended the final dividend of Rs 22 per equity Share (i.e. 220%) , subject to the approval of the shareholders.
Aditya Bir. Nuv. ( 23-May-17 )
Aditya Birla Nuvo announced that the operations at Jaya Shree Textiles Division of the Company at Rishra, Hoogly, West Bengal have been restored and the working has now become normal with effect from 20 May 2017.

While normal working has started, discussions are on with the workmen and the labour office officials in the State of West Bengal to bring about a closure of the various outstanding issues.

The contribution loss on account of the strike that began on 16 May 2017 is estimated to be around Rs 3.90 crore.

J B Chem & Pharm ( 23-May-17 )
The Board of Directors of J B Chemicals & Pharmaceuticals at its meeting held on 23 May 2017 has approved the Buy-back of up to 12,50,000 fully paid up Equity Shares of face value of Rs. 2/- each by the Company (representing 1.47% of the total paid up Equity Share capital of the Company) at a price of Rs. 400/- (Rupees four hundred) per Equity Share payable in cash for a total consideration not exceeding Rs. 50/- crores (Rupees fifty crores only) (excluding transaction costs such as fees, brokerage, taxes, duties, etc), which is not exceeding 10% of the total paid-up Equity Share capital and free reserves (including securities premium account) as per the audited financial statement of the Company for the financial year ended on 31 March 2017, through the "Tender Offer" route as prescribed under the Securities and Exchange Board of India (Buy Back of Securities) Regulations, 1998 as amended, on a proportionate basis, from the Equity Shareholders/beneficial owners of the Equity Shares of the Company including promoters, members of promoter group and persons acting in concert, as on the record date.
Back Top
Source:Capital Market

Member Code : NCDEX - 00241 | MCX - 31435
SEBI Regn. Nos : BSE INB010643030 | NSE(EQ) INB230643037 | NSE(FUT) INF230643037 FOR INVESTORS GRIEVANCE : complaints@cilsecurities.com
FOR DP GRIEVANCE : grievance@cilsecurities.com
Privacy Policy  |  Disclaimer | BrokerNorms |  BSE Complaints
Useful Links :  NSE | BSE  | CDSL | MCX  | NCDEX | SEBI | RBI
Designed , Developed & Powered By C-MOTS Infotech
(ISO 9001:2015 certified)